BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11277171)

  • 1. Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kinetics.
    Marley SB; Lewis JL; Zheng B; Davidson RJ; Davis JG; McDonald C; Alenzi FQ; Goldman JM; Gordon MY
    Bone Marrow Transplant; 2001 Feb; 27(3):241-8. PubMed ID: 11277171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
    Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
    Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of engraftment after autologous peripheral blood progenitor cell transplantation: CD34, colony-forming unit-granulocyte-macrophage, or both?
    Jansen EM; Hanks SG; Terry C; Akard LP; Thompson JM; Dugan MJ; Jansen J
    Transfusion; 2007 May; 47(5):817-23. PubMed ID: 17465946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factor.
    Boogaerts MA; Demuynck H
    Eur J Cancer; 1994; 30A Suppl 3():S34-9. PubMed ID: 7535071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation.
    Sautois B; Baudoux E; Salmon JP; Michaux S; Schaaf-Lafontaine N; Pereira M; Paulus JM; Fillet G; Beguin Y
    Haematologica; 2001 Nov; 86(11):1209-18. PubMed ID: 11694408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
    Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA
    Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of erythropoietin and recombinant cytokines on colony formation and self-renewal by erythroid burst-forming units and granulocyte-macrophage progenitors from mobilized peripheral blood progenitor cells.
    Zheng B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):6-12. PubMed ID: 12513828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The synergistic effect of thrombopoietin in erythropoiesis with erythropoietin and/or IL-3 and myelopoiesis with G-CSF or IL-3 from umbilical cord blood cells of full-term neonates.
    Liang DC; Shih LY; Kuo MC; Chai IJ; Su TH; Chen SH; Liu HC; Shimosaka A
    Pediatr Hematol Oncol; 2001 Sep; 18(6):383-91. PubMed ID: 11554233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers.
    Sato N; Sawada K; Takahashi TA; Mogi Y; Asano S; Koike T; Sekiguchi S
    Exp Hematol; 1994 Sep; 22(10):973-8. PubMed ID: 7522184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progenitor content of autologous grafts: mobilized bone marrow vs mobilized blood.
    Dahl E; Burroughs J; DeFor T; Verfaillie C; Weisdorf D
    Bone Marrow Transplant; 2003 Sep; 32(6):575-80. PubMed ID: 12953129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways implicated in hematopoietic progenitor cell proliferation and differentiation.
    Bugarski D; Krstic A; Mojsilovic S; Vlaski M; Petakov M; Jovcic G; Stojanovic N; Milenkovic P
    Exp Biol Med (Maywood); 2007 Jan; 232(1):156-63. PubMed ID: 17202596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent mobilisation of haematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF.
    Höglund M; Smedmyr B; Simonsson B; Tötterman T; Bengtsson M
    Bone Marrow Transplant; 1996 Jul; 18(1):19-27. PubMed ID: 8831991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
    Isaikina Y; Kustanovich A; Svirnovski A
    Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of standardized large volume leukapheresis (LVL) in patients do not show a recruitment phenomenon of peripheral blood progenitor cells (PBPC).
    Cassens U; Momkvist PH; Zuehlsdorf M; Mohr M; Kienast J; Berdel WE; Sibrowski W
    Bone Marrow Transplant; 2001 Jul; 28(1):13-20. PubMed ID: 11498739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.